1. Home
  2. SLNO vs MRCY Comparison

SLNO vs MRCY Comparison

Compare SLNO & MRCY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SLNO
  • MRCY
  • Stock Information
  • Founded
  • SLNO 1999
  • MRCY 1981
  • Country
  • SLNO United States
  • MRCY United States
  • Employees
  • SLNO N/A
  • MRCY N/A
  • Industry
  • SLNO Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • MRCY
  • Sector
  • SLNO Health Care
  • MRCY
  • Exchange
  • SLNO Nasdaq
  • MRCY Nasdaq
  • Market Cap
  • SLNO 3.7B
  • MRCY 4.6B
  • IPO Year
  • SLNO 2014
  • MRCY 1998
  • Fundamental
  • Price
  • SLNO $47.48
  • MRCY $73.00
  • Analyst Decision
  • SLNO Strong Buy
  • MRCY Buy
  • Analyst Count
  • SLNO 9
  • MRCY 8
  • Target Price
  • SLNO $114.89
  • MRCY $72.13
  • AVG Volume (30 Days)
  • SLNO 2.3M
  • MRCY 560.6K
  • Earning Date
  • SLNO 11-04-2025
  • MRCY 11-04-2025
  • Dividend Yield
  • SLNO N/A
  • MRCY N/A
  • EPS Growth
  • SLNO N/A
  • MRCY N/A
  • EPS
  • SLNO N/A
  • MRCY N/A
  • Revenue
  • SLNO $98,675,000.00
  • MRCY $932,798,000.00
  • Revenue This Year
  • SLNO N/A
  • MRCY $6.17
  • Revenue Next Year
  • SLNO $181.30
  • MRCY $8.23
  • P/E Ratio
  • SLNO N/A
  • MRCY N/A
  • Revenue Growth
  • SLNO N/A
  • MRCY 8.63
  • 52 Week Low
  • SLNO $41.50
  • MRCY $37.28
  • 52 Week High
  • SLNO $90.32
  • MRCY $85.33
  • Technical
  • Relative Strength Index (RSI)
  • SLNO 34.34
  • MRCY 42.17
  • Support Level
  • SLNO $41.80
  • MRCY $71.84
  • Resistance Level
  • SLNO $50.78
  • MRCY $76.52
  • Average True Range (ATR)
  • SLNO 3.68
  • MRCY 2.65
  • MACD
  • SLNO -2.05
  • MRCY -0.72
  • Stochastic Oscillator
  • SLNO 19.37
  • MRCY 13.09

About SLNO Soleno Therapeutics Inc.

Soleno Therapeutics Inc is a biopharmaceutical company developing novel therapeutics for the treatment of rare diseases. Its product candidate DCCR (Diazoxide Choline) Extended-Release tablets, is a proprietary extended-release formulation of a crystalline salt of diazoxide. DCCR has demonstrated the ability to activate the KATP channel in the brain, pancreas, and fat tissue.

About MRCY Mercury Systems Inc

Mercury Systems Inc is a commercial technology company serving the aerospace and defense industry. The company envisions, creates, and delivers secure open architecture solutions powering a broad range of mission-critical applications in challenging and demanding environments. Its Mercury Processing Platform spans the full breadth of signal processing from radio frequency front end to the human-machine interface to convert meaningful data, gathered in remote and hostile environments, into critical decisions. The company manufactures components, products, modules, and subsystems and sells to defense prime contractors, the U.S. government, original equipment manufacturers, and commercial aerospace companies. Geographically, it derives maximum revenue from the United States.

Share on Social Networks: